Dr. Jorge J. Corona, MD

Dr. Corona practices at Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health.

Dr. Corona's NPI, 1104816404, was assigned on October 27, 2005. Dr. Corona graduated from Universidad La Salle School of Medicine in 1995. Dr. Corona's Texas license number on file is M5109.

Dr. Corona's primary practice is Baylor University Medical Center, at 3500 Gaston Ave, Dallas, TX 75246 in Dallas County. The practice phone is (214) 820-8082.

Dr. Corona's primary practice is Baylor University Medical Center in Dallas, Texas, part of Baylor Scott & White Health. Dr. Corona is also affiliated with William P. Clements Jr. University Hospital. Dmand AI also links Dr. Corona to 3 more hospitals, 2 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corona practices, 7 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Corona's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dr. Corona is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Corona's licenses on file in 2 states: Texas and Colorado.

Dmand AI lists conjunctivitis, dry eye, eye infection or inflammation, eyelid inflammation, inflammation of iris, vision problems and visual impairment and blindness among the conditions Dr. Corona treats.

CMS data shows 3,831 Medicare services from Dr. Corona across 23 procedure codes in 2024, for 455 Medicare patients. Medicare paid $190,105 for them.

CMS counts 455 Medicare patients who saw Dr. Corona in 2024. The largest group is 75 to 84, with 202 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Corona's median patient age at 72, with 57% women.

In 2024, Dr. Corona wrote 780 Medicare Part D claims for 415 patients. 82% of them were for generic drugs. CMS names the drug for 726 of them, across 5 drugs with 11 or more claims each, at $17,101 in total drug cost. In 2023, CMS named 622 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Corona for performance year 2024, reported as part of a group. Dr. Corona accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Corona as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Corona. The most frequent topics are Visual Acuity. Dr. Corona's most frequent co-authors are Geert Craenen, MD and Kenn Alan Freedman, MD.

CMS Open Payments shows 93 general payments to Dr. Corona from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Horizon Pharma plc paid the most, $944.

Dmand AI lists 2 awards for Dr. Corona, most recently CMS Stage 1 EHR in 2012.

Dr. Corona graduated from Universidad La Salle School of Medicine in 1995. Dr. Corona is a member of AAO.

Dr. Corona is in network with 23 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.